3-amino-1-arylpropyl indoles and aza-substituted indoles and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S414000, C514S425000, C514S378000, C514S397000, C514S372000, C548S469000, C548S503000, C548S247000, C548S152000, C548S159000, C548S312100, C548S335500, C548S235000, C548S361100, C548S364700

Reexamination Certificate

active

07446118

ABSTRACT:
The present invention provides compounds of the formula:or pharmaceutically acceptable salts, solvates or prodrugs thereof,wherein p, Ar, R1, R2, R3, Ra, Rb, Rc, Rdand Reare defined herein. Also provided are pharmaceutical compositions, methods of using, and methods of preparing the compounds.

REFERENCES:
patent: 2708197 (1955-05-01), Speeter
patent: 2752358 (1956-06-01), Ehrhart et al.
patent: 2984670 (1961-05-01), Szmuszkovics et al.
patent: 7390835 (2008-06-01), Shah et al.
patent: 2005/0222148 (2005-10-01), Kim et al.
patent: 2006/0025467 (2006-02-01), Greenhouse et al.
patent: 849108 (1949-07-01), None
patent: 0 179 546 (1986-04-01), None
patent: 0 509 402 (1992-10-01), None
patent: 0 534 343 (1993-03-01), None
patent: 0 600 830 (1994-06-01), None
patent: 0 506 532 (1994-09-01), None
patent: 0 775 694 (1997-05-01), None
patent: 0 780 389 (1997-06-01), None
patent: 0 887 348 (1998-12-01), None
patent: 2 814 073 (2000-09-01), None
patent: 705652 (1950-09-01), None
patent: 992731 (1963-09-01), None
patent: 03 14562 (1991-01-01), None
patent: WO 94/12478 (1994-06-01), None
patent: WO 97/10219 (1997-03-01), None
patent: WO 97/44329 (1997-11-01), None
patent: WO 97/46511 (1997-12-01), None
patent: WO 98/43942 (1998-10-01), None
patent: WO 99/16755 (1999-04-01), None
patent: WO 99/21553 (1999-05-01), None
patent: WO 99/21557 (1999-05-01), None
patent: WO 00/02551 (2000-01-01), None
patent: WO 00/02551 (2000-01-01), None
patent: WO 00/02556 (2000-01-01), None
patent: WO 01/32622 (2001-05-01), None
patent: WO 02/069965 (2002-09-01), None
patent: WO 03/035005 (2003-05-01), None
patent: WO 03/035005 (2003-05-01), None
patent: WO 03/053938 (2003-07-01), None
patent: WO 03/057213 (2003-07-01), None
patent: WO 03/057213 (2003-07-01), None
patent: WO 03/066622 (2003-08-01), None
patent: WO 2005/005439 (2005-01-01), None
Norepinephrine Transporter, Wikipedia.
Ganellin, C.R., et. al., “Aminoalkylation of Metal Derivatives of Indole. Part III. Alkylation of Lithio-derivatives of N-Substituted Indoles with 1-Chloro-2-dimethyl-aminoethane,”J. Chem. Society(1969) pp. 1537-1540.
Kraxner, J., et. al., “Azepino- and Diazepinoindoles: Synthesis and Dopamine Receptor Binding Profiles,”Archiv. der Pharmazie. (2000) vol. 333 (9) pp. 287-292.
Lindner, E., “Über ein neues Antihistaminicum, das-1-Phenyl-1-Pyridyl-(2)-3-dimethylaminopropan und sein Salz mit der p-Aminosalicylsäure (A vil)”, Naunyn-Schmiedbergs Archiv für Pharmakologie und Experimentelle Pathologie, (1950) vol. 211, pp. 328-344.
Schmidt, A. M. et. al., “Synthesis of Pharmacologically Relevant Indoles with Amine Side Chains via Tandem Hydroformylation/Fischer Indole Synthesis,”J. Organic Chemistry(2005) vol. 70 (14) pp. 5528-5535.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

3-amino-1-arylpropyl indoles and aza-substituted indoles and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-amino-1-arylpropyl indoles and aza-substituted indoles and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-amino-1-arylpropyl indoles and aza-substituted indoles and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4050133

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.